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OBJECTIVE—Recent epidemiological studies have shown that
background exposure to persistent organic pollutants (POPs)—
xenobiotics accumulated in adipose tissue—is strongly associ-
ated with type 2 diabetes. Hyperglycemia is the cause of long-
term complications of diabetes as well as diabetes itself, and
POPs are well-known neurotoxicants. This study was performed
to explore whether POPs are associated with peripheral neurop-
athy, a common long-term complication of diabetes, in people
with glucose abnormalities.
RESEARCH DESIGN AND METHODS—We studied cross-
sectional associations of peripheral neuropathy with 25 POPs,
each of which were detectable in at least 60% of study subjects,
in 246 subjects aged 40 years with diabetes or impaired fasting
glucose (IFG) using National Health and Nutrition Examination
Survey 1999–2002 datasets.
RESULTS—Among ﬁve subclasses of POPs, organochlorine
pesticides showed a strong dose-response relation with preva-
lence of peripheral neuropathy; adjusted ORs were 1.0, 3.6, and
7.3 (P for trend 0.01), respectively, across three categories of
serum concentrations of organochlorine pesticides. Further-
more, when we restricted the analyses to 187 participants with
A1C 7%, the adjusted ORs were still 1.0, 3.9, and 6.7 (P for trend
0.01). Organochlorine pesticides were also strongly associated
with the prevalence of A1C 7%; adjusted ORs were 1.0, 2.5, and
5.0 (P for trend 0.01). Speciﬁc POPs belonging to organochlo-
rine pesticides showed similar positive associations.
CONCLUSIONS—This study suggests that background expo-
sure to organochlorine pesticides may be associated with higher
risk of peripheral neuropathic complications among those with
glucose abnormalities, even beyond the inﬂuence of diabetes
itself. Diabetes 57:3108–3111, 2008
R
ecent epidemiological studies have found that
background exposure to persistent organic pol-
lutants (POPs)—xenobiotics accumulated in ad-
ipose tissue—is associated with type 2 diabetes,
insulin resistance, and metabolic syndrome (1–3), suggest-
ing that POPs may play a key role in their pathogenesis.
Among various subtypes of POPs, organochlorine pesti-
cides were most consistently and strongly associated with
disturbances of glucose metabolism.
Hyperglycemia itself not only deﬁnes type 2 diabetes but
also is the cause of its most characteristic symptoms and
long-term complications (4). Epidemiological data indi-
cate that the degree and duration of hyperglycemia is
associated with the microvascular complications of diabe-
tes (5,6). Peripheral neuropathy is a common long-term
complication of diabetes (7).
A1C, a biological correlate of long-term control of blood
glucose, is a recognized surrogate measure for the risk of
diabetes complications (4). We hypothesized that POPs
would be associated with poorer glycemic control and
consequent excess risk of peripheral neuropathy among
those with glucose abnormalities. Furthermore, exposure
to chemicals such as POPs can increase the risk of neuron
damage (8–12). Therefore, it is also possible that POPs
increase the risk of peripheral neuropathy directly. This
study was performed in people with diabetes or impaired
fasting glucose (IFG) to explore whether serum concen-
trations of POPs were associated with A1C and peripheral
neuropathy.
RESEARCH DESIGN AND METHODS
The 1999–2002 National Health and Nutrition Examination Survey (NHANES)
was designed to be nationally representative of the U.S. noninstitutionalized
civilian population. Details of the NHANES protocol are available elsewhere
(13,14). Serum concentrations of various biologically important POPs or their
metabolites were measured in subsamples of the NHANES 1999–2002 surveys
(15).
Venous blood samples were collected and shipped weekly at 20°C. POPs
were measured by high-resolution gas chromatography/high-resolution mass
spectrometry using isotope dilution for quantiﬁcation. All these analytes were
measured using a modiﬁcation of the method of Turner et al. (16). The POPs
were reported on a lipid-adjusted basis using concentrations of serum total
cholesterol and triglycerides. Although 49 POPs were measured in both
NHANES 1999–2000 and 2001–2002, to avoid bias in estimation among those
below the limit of detection, we selected the 25 POPs for which at least 60%
of study subjects had concentrations more than the logarithm of odds, as
follows: three polychlorinated dibenzo-p-dioxins (PCDDs), four polychlori-
nated dibenzofurans (PCDFs), ﬁve dioxin-like polychlorinated biphenyls
(PCBs), seven non–dioxin-like PCBs, and six organochlorine pesticides.
There were 246 patients with diabetes or IFG aged 40 years who had
information on serum concentrations of POPs. Participants were considered
to have diabetes if 1) their fasting plasma glucose was 126 mg/dl or their
nonfasting plasma glucose was 200 mg/dl or 2) they were taking insulin or
an anti-diabetes oral agent. IFG was deﬁned as fasting plasma glucose 100
mg/dl. Exclusion of nonfasting subjects did not greatly change the estimates.
However, as their exclusion substantially limited power of statistical tests, we
presented the results based on 246 participants with diabetes or glucose
impairment. In one analysis, the 642 participants with normal fasting or
nonfasting glucose (100 mg/dl) were included.
Deﬁnition of peripheral neuropathy and poor glycemic control. Periph-
eral neuropathy was operationalized by testing foot sensation using a 5.07-
gauge Semmes-Weinstein nylon monoﬁlament. Three plantar metatarsal sites
(hallux and ﬁrst and ﬁfth metatarsal heads) were tested on each foot in
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3108 DIABETES, VOL. 57, NOVEMBER 2008random order. Peripheral neuropathy was deﬁned as having one or more
insensate sites. Poor glycemic control was deﬁned as A1C 7.0%.
Statistical analyses. For analyses of POPs and peripheral neuropathy or
poor glycemic control, we calculated cumulative measures of ﬁve subclasses
of POPs by summing the ranks of speciﬁc POPs that belong to each subclass
(three PCDDs, four PCDFs, ﬁve dioxin-like PCBs, seven non–dioxin-like
PCBs, and the six organochlorine pesticides). Detectable values of each POP
were individually ranked, and the rank orders of the individual POPs in each
subclass were summed to arrive at the subclass value. All undetectable values
were ranked as zero. The summary values were categorized in tertiles. For
analyses of individual POPs, correlation coefﬁcients between the ranked POP
and various outcomes were presented.
Logistic regression models were used to calculate multivariable-adjusted
odd ratios (ORs). Potential confounders were age, sex, race/ethnicity, poverty
income ratio, duration of diabetes (years), hypertension (yes or no), BMI,
cigarette smoking (never, former, or current), cotinine concentrations (in
nanogramsg per milliliter), alcohol consumption (in grams per day), and
leisure-time physical activity (vigorous, moderate, or none). A1C was added as
a possible confounder when we examined the associations with peripheral
neuropathy. Further adjustment for education or insulin medication had little
effect on ﬁndings. We substituted median values of study subjects for missing
poverty income ratio, BMI, cotinine concentrations, or alcohol consumption
in 25 subjects.
All statistical analyses were performed with SAS 9.1 and SUDAAN 9.0.
Estimates of main results were calculated accounting for stratiﬁcation and
clustering (17), adjusting for age, race/ethnicity, and poverty income ratio
instead of using sample weights; this adjustment has been regarded as a good
compromise between efﬁciency and bias (17,18). As results were very similar
with SAS 9.1 and SUDAAN 9.0, we present the results based on SAS 9.1.
RESULTS
The characteristics of study subjects are summarized in
Table 1. In total, there were 246 participants (136 with
diabetes and 110 with IFG). Mean  SD age was 62.5 
12.3 years in participants with diabetes and 64.9  12.9
years in participants with IFG. In 41.9% of the patients with
diabetes, A1C 7%. Mean duration of diabetes among
diabetic subjects was 10.9 years, and 22.1% of participants
were treated with insulin.
The prevalences of peripheral neuropathy were 13.6%
among participants with IFG and 19.9% among those with
diabetes. Among ﬁve subclasses of POPs, only organochlo-
rine pesticides were strongly associated with the risk of
peripheral neuropathy, with adjusted ORs of 1.0, 3.6, and
7.3, respectively, across tertiles of serum concentrations
of organochlorine pesticides (P for trend 0.01) (Table 2).
This strong association was obtained even after adjust-
ment for A1C. Furthermore, when we restricted the anal-
yses to 187 participants with A1C 7%, the adjusted ORs
were still1.0, 3.9, and 6.7 (P for trend 0.01). The associ-
ation of organochlorine pesticides with peripheral neurop-
athy persisted in participants both younger and older than
65 years; adjusted ORs were respectively 1.0, 3.1, and 12.3
among subjects aged 65 years and 1.0, 3.3, and 10.3
among those aged 65 years (P for trend 0.01). Among
other subclasses of POPs, PCDD and dioxin-like PCBs
tended to show positive associations but failed to reach
statistical signiﬁcance. However, when we repeated the
same analyses in 642 participants with normal glucose
tolerance, in whom peripheral neuropathy prevalence was
13.1%, organochlorine pesticides were not associated with
peripheral neuropathy; adjusted ORs were respectively
1.0, 1.3, and 0.7 (P for interaction 0.01).
Organochlorine pesticides were also strongly associated
with the risk of A1C 7% (Table 2). Across the tertiles of
organochlorine pesticides, adjusted ORs of having A1C
7% were respectively 1.0, 2.5, and 5.0 (P for trend 0.01).
Dioxin-like PCBs also showed statistically nonsigniﬁcant
trends. In Table 3, we present adjusted correlation coefﬁ-
cients of speciﬁc POPs with peripheral neuropathy and
A1C. In general, the trends of speciﬁc POPs were similar
to those of the subclass to which they belong; most of
the speciﬁc POPs among organochlorine pesticides were
positively associated with peripheral neuropathy and A1C.
Some POPs belonging to PCBs also showed positive
trends.
DISCUSSION
This study raises the possibility that background exposure
to some POPs may increase the risk of peripheral neurop-
athy among patients with diabetes or IFG. In this study,
organochlorine pesticides were the only subclass of POPs
that was associated with the prevalence of peripheral
neuropathy and was also strongly associated with poor
glycemic control. In fact, organochlorine pesticides were
the class of POPs that was most consistently associated
with type 2 diabetes, insulin resistance, and metabolic
syndrome in our previous studies (1–3). However, organo-
chlorine pesticides were not associated with peripheral
neuropathy among participants with normal glucose toler-
ance, suggesting that an interaction between organochlo-
rine pesticides and hyperglycemia affects the risk of
peripheral neuropathy.
There can be a question whether statistical adjustment
for age and BMI is sufﬁcient to fully eliminate their
confounding effects. Although organochlorine pesticides
are typically stored in adipose tissue, the association of
BMI with organochlorine pesticides is not strong (1–3),
and statistical adjustment should work well. However,
serum concentrations of organochlorine pesticides are
strongly associated with age (1–3), and age is also an
important risk factor for peripheral neuropathy. To exam-
ine whether adjustment for age was sufﬁcient, we consid-
ered two sensitivity analyses. First, we stratiﬁed by age
and found the same associations of organochlorine pesti-
cides with peripheral neuropathy in both younger and
older age-groups. Second, if our ﬁnding were due to age
confounding, there should have been similar associations
between organochlorine pesticides and peripheral neurop-
athy among subjects with normal glucose tolerance. As
organochlorine pesticides were associated with peripheral
neuropathy only among subjects with abnormal glucose
tolerance, any residual confounding effect due to age may
not explain the current ﬁndings.
Until now, the strongest risk factors for diabetes com-
plications have been poor glycemic control and diabetes
duration (4,5). In addition, other risk factors such as age,
TABLE 1
Characteristics of participants
Diabetes IFG
n 136 110
Age (years) 62.5  12.3 64.9  12.9
Male 48.5 58.2
White race 39.0 53.6
BMI (kg/m
2) 30.8  6.5 29.6  5.3
Smoker 8.1 18.2
Exercise 41.9 48.1
A1C (%) 7.5  1.9 5.8  0.4
A1C 7% 41.9 1.8
Duration of diabetes (years) 10.9  14.8 —
Insulin treatment 22.1 —
Data are means  SD or percent.
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tribute in developing diabetes complications (4,5). In this
study, these conventional risk factors appeared to be
associated with the prevalence of peripheral neuropathy,
although most of them failed to reach statistical signiﬁ-
cance, consistent with small sample sizes. Compared with
the degree of association between peripheral neuropathy
and conventional risk factors, serum concentrations of
organochlorine pesticides were very strongly associated
with peripheral neuropathy. Tight glycemic control in
diabetes through diet and medication is one of the corner-
stones of management of diabetes. However, if environ-
mental exposure to organochlorine pesticides is involved
in disturbance of glucose metabolism, the current thera-
peutic approach may be insufﬁcient for glucose control.
Because people are exposed to organochlorine pesticides
through food consumption, it could be helpful to identify
foods containing organochlorine pesticides so that dia-
betic patients can avoid them.
At least two mechanisms exist that could lead to a
causal link between organochlorine pesticides and periph-
eral neuropathy. First, poor glycemic control caused by
organochlorine pesticides may increase the risk of diabe-
tes complications. The positive association between or-
ganochlorine pesticides and A1C supports this possibility.
In addition, organochlorine pesticides themselves could
directly increase the risk of diabetes complications. It is
well known that various pesticides have a direct toxic
effect on nervous tissue (11). However, it is still unclear
whether, with chronic environmental exposure, low con-
centrations of a mixture of pesticides can also act as
neurotoxicants (11). Diabetic patients and those with IFG
may be more susceptible than those with normal glucose
tolerance to chronic exposure to low concentrations of
organochlorine pesticides because of an already higher
risk of peripheral neuropathy due to hyperglycemia. Im-
portantly, these two mechanisms, hyperglycemia and
organochlorine pesticides, may act synergistically to in-
crease the risk of peripheral neuropathy among diabetic
patients.
This study has several limitations. First, the cross-
sectional study design in NHANES does not allow infer-
ences regarding the causal relationship between POPs and
diabetes complications. However, as neurotoxicity of
some POPs is a well-known phenomenon, our results are
biologically highly plausible. Second, the sample size was
small. Thus, despite consistency of ﬁndings, we could not
rule out a possibility of chance in some associations.
Third, there would be misclassiﬁcation in deﬁning diabe-
tes and impaired glucose tolerance, and loss of vibration
sensation on a single occasion does not fully characterize
neuropathy clinically.
TABLE 2
Adjusted ORs and 95% CIs of prevalence of peripheral neuropathy or A1C 7% by tertiles of POPs
Tertile 1 Tertile 2 Tertile 3 Ptrend
Peripheral neuropathy
PCDDs
n cases/subjects 6/82 16/82 20/82
OR (95% CI) Referent 2.5 (0.9–7.2) 2.4 (0.8–6.9) 0.15
PCDFs
n cases/subjects 11/81 12/83 19/82
OR (95% CI) Referent 0.7 (0.3–1.9) 1.0 (0.4–2.5) 0.96
Dioxin-like PCBs
n cases/subjects 6/82 12/82 24/82
OR (95% CI) Referent 1.5 (0.5–4.4) 2.2 (0.7–6.8) 0.15
Non–dioxin-like PCBs
n cases/subjects 7/82 11/82 24/82
OR (95% CI) Referent 1.0 (0.3–3.0) 1.7 (0.6–5.1) 0.22
Organochlorine pesticides
n cases/subjects 4/82 14/82 24/82
OR (95% CI) Referent 3.6 (1.1–12.2) 7.3 (2.1–25.3) 0.01
A1C 7%
PCDDs
n cases/subjects 21/82 16/82 22/82
OR (95% CI) Referent 1.0 (0.5–2.4) 1.3 (0.5–3.0) 0.58
PCDFs
n cases/subjects 20/81 17/83 22/82
OR (95% CI) Referent 0.9 (0.4–2.1) 1.4 (0.6–3.2) 0.42
Dioxin-like PCBs
n cases/subjects 19/82 21/82 19/82
OR (95% CI) Referent 2.0 (0.9–4.7) 2.1 (0.8–5.4) 0.13
Non–-dioxin-like PCBs
n cases/subjects 20/82 20/82 19/82
OR (95% CI) Referent 1.4 (0.6–3.3) 1.4 (0.6–3.7) 0.46
Organochlorine pesticides
n cases/subjects 12/82 19/82 28/82
OR (95% CI) Referent 2.5 (1.0–6.5) 5.0 (1.8–13.4) 0.01
ORs adjusted for age, sex, race, poverty income ratio, duration of diabetes, hypertension, BMI, cigarette smoking, serum cotinine, exercise,
alcohol consumption, and A1C (A1C not included as a covariate in the analyses with the outcome of A1C 7%). Detectable values of each
POP were individually ranked and the rank orders of the individual POPs in each subclass were summed to arrive at the subclass value. All
undetectable values were ranked as 0. The summary values were categorized by tertiles of the sum of ranks.
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serum concentrations of organochlorine pesticides and
prevalence of peripheral neuropathy and poor glycemic
control among patients with diabetes or IFG. If these
ﬁndings are conﬁrmed in prospective studies, new thera-
peutic approaches such as avoiding POPs or an increased
excretion of POPs from the human body can be developed
for the management of type 2 diabetes.
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Adjusted correlation coefﬁcients of 25 POPs with peripheral
neuropathy or A1C 7% (N  246)
Peripheral
neuropathy A1C 7%
PCDDs
D03 0.12 0.02
D05 0.04 0.08
D07 0.05 0.02
PCDFs
F03 0.05 0.01
F04 0.03 0.10
F05 0.12 0.06
F08 0.04 0.05
Dioxin-like PCBs
PCB074 0.01 0.09
PCB118 0.06 0.13*
PCB126 0.14* 0.15*
PCB156 0.05 0.08
PCB169 0.02 0.06
Non–dioxin-like PCBs
PCB099 0.07 0.06
PCB138 0.05 0.11
PCB146 0.03 0.11
PCB153 0.05 0.09
PCB170 0.01 0.08
PCB180 0.02 0.09
PCB187 0.01 0.11
OC pesticides
OXY 0.13 0.14*
TNA 0.17† 0.12
PDE 0.14* 0.10
PDT 0.11 0.14*
BHC 0.14* 0.23†
HPE 0.20† 0.22†
Correlation coefﬁcients adjusted for age, sex, race, poverty income
ratio, duration of diabetes, hypertension, BMI, cigarette smoking,
serum cotinine, exercise, alcohol consumption, and A1C (A1C not
included as a covariate in the analyses with the outcome of
A1C7%). NHANES abbreviations: BHC: Beta-hexachlorocyclohex-
ane; D03: 1,2,3,6,7,8,-Hexachlorodibenzo-p-dioxin; D05: 1,2,3,4,6,7,8-
Heptachlorodibenzo-p-dioxin; D07: 1,2,3,4,6,7,8,9-octachlorodibenzo-
p-dioxin; F03: 2,3,4,7,8-Pentachlorodibenzofuran; F04: 1,2,3,4,7,8-
Hexachlorodibenzofuran; F05: 1,2,3,6,7,8-Hexachlorodibenzofuran;
F08: 1,2,3,4,6,7,8-Heptachlorodibenzofuran; HPE: Heptachlor epox-
ide; OXY: Oxychlordane; PCB074: 2,4,4’,5-Tetrachlorobiphenyl;
PCB118: 2,3’,4,4’,5-Pentachlorobiphenyl; PCB126: 3,3’,4,4’,5-Penta-
chlorobiphenyl; PCB156: 2,3,3’,4,4’,5-Hexachlorobiphenyl; PCB169:
3,3’,4,4’,5,5’-Hexachlorobiphenyl; PCB099: 2,2’,4,4’,5-Pentachlorobi-
phenyl; PCB138: 2,2’,3,4,4’,5-Hexachlorobiphenyl; PCB146: 2,2’,3,4,5’,5-
Hexachlorobiphenyl; PCB153: 2,2’,4,4’,5,5’-Hexachlorobiphenyl;
PCB170: 2,2’,3,3’,4,4’,5-Heptachlorobiphenyl; PCB180: 2,2’,3,4,4’,5,5’-
Heptachlorobiphenyl; PCB187: 2,2’,3,4’,5,5’,6-Heptachlorobiphenyl;
PDE: p,p’-Dichlorodiphenyldichloroethylene; PDT: p,p’-Dichlorodi-
phenyltrichloroethane; TNA: Trans-Nonachlor. *P  0.05, †P  0.01.
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